To create a Parkinson's disease model, Cerebral Organoids (Cat. No. CIPO-BWL001K) were created using ACROBiosystems' Cerebral Organoid Differentiation Kit (Cat. No. RIPO-BWM001K).

Parkinson’s disease doesn’t begin in the brain at all—it starts in the digestive system, sometimes decades before the first tremor appears.

In the past 50 years, progress in treatment has been slow. The main therapy is a drug called L-DOPA, which was first used in the 1960s and was revolutionary at the time. But L-DOPA is not a cure and ...

Parkinson’s disease diagnoses have doubled since the 1990s, affecting 10 million people around the world, including “Back to the Future” icon Michael J. Fox and science communication ...

Explore how gut health influences Parkinson’s disease and prevention tips By Cameron French Jan 04, 2025 2:50 pm Photo credit: Shutterstock.com / Prostock-studio ...

Parkinson’s disease (PD) occurs when nerve cells in the brain that produce dopamine—a neurotransmitter responsible for many important body functions, including movement—begins to deteriorate. As a ...

Another 2024 study found that Parkinson’s disease patients taking lixisenatide, an injectable medication used to treat diabetes, experienced less progression of motor symptoms than people with ...

Parkinson’s disease is a brain disorder that causes unintended or uncontrollable movements, such as shaking, stiffness, and difficulty with balance and coordination, according to the National ...

Parkinson’s disease treatments “One of the main issues with Parkinson’s disease is that there is low dopamine in the brain — that causes a lot of the physical symptoms of the disease ...

Dr. Kubota, explains, "Investigating how Parkinson's disease medications affect decision-making will help the public to better understand the complexity of the disease and its treatment.